{"title":"Protocol for Controlling the Strand Selectivity of siRNA Using Acyclic Artificial Nucleic Acids","authors":"Jumpei Ariyoshi, Hiroyuki Asanuma, Yukiko Kamiya","doi":"10.1002/cpz1.70103","DOIUrl":null,"url":null,"abstract":"<p>Small interfering RNA (siRNA) has emerged as a promising therapeutic candidate against previously intractable diseases. An effective siRNA must have high on-target activity while off-target effects are minimized. This balance can be achieved by enhancing the selectivity of the antisense strand through sequence optimization and appropriate chemical modifications. Acyclic artificial nucleic acids such as serinol nucleic acids (SNA) have demonstrated on-target activity while suppressing off-target effects. This article provides guidelines for designing SNA-modified siRNA and outlines a method for the experimental evaluation of the on-target and off-target activities of siRNAs, ensuring accurate functional validation in cell systems. These protocols benefit researchers developing siRNA-based therapeutics to optimize siRNA selectivity and efficacy while minimizing off-target effects through innovative design strategies. © 2025 Wiley Periodicals LLC.</p><p><b>Basic Protocol 1</b>: Design of SNA-modified siRNA</p><p><b>Basic Protocol 2</b>: Design and preparation of vector plasmids using inverse PCR</p><p><b>Alternate Protocol</b>: Design and preparation of vector plasmid using restriction enzymes and ligase</p><p><b>Basic Protocol 3</b>: Evaluation of the on- and off-target effects of siRNAs using the dual-luciferase assay</p><p><b>Support Protocol 1</b>: Agarose gel electrophoresis and protocol for purifying DNA from gels</p><p><b>Support Protocol 2</b>: Transformation and amplification of plasmids</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"5 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current protocols","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cpz1.70103","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Small interfering RNA (siRNA) has emerged as a promising therapeutic candidate against previously intractable diseases. An effective siRNA must have high on-target activity while off-target effects are minimized. This balance can be achieved by enhancing the selectivity of the antisense strand through sequence optimization and appropriate chemical modifications. Acyclic artificial nucleic acids such as serinol nucleic acids (SNA) have demonstrated on-target activity while suppressing off-target effects. This article provides guidelines for designing SNA-modified siRNA and outlines a method for the experimental evaluation of the on-target and off-target activities of siRNAs, ensuring accurate functional validation in cell systems. These protocols benefit researchers developing siRNA-based therapeutics to optimize siRNA selectivity and efficacy while minimizing off-target effects through innovative design strategies. © 2025 Wiley Periodicals LLC.
Basic Protocol 1: Design of SNA-modified siRNA
Basic Protocol 2: Design and preparation of vector plasmids using inverse PCR
Alternate Protocol: Design and preparation of vector plasmid using restriction enzymes and ligase
Basic Protocol 3: Evaluation of the on- and off-target effects of siRNAs using the dual-luciferase assay
Support Protocol 1: Agarose gel electrophoresis and protocol for purifying DNA from gels
Support Protocol 2: Transformation and amplification of plasmids
使用无环人工核酸控制siRNA链选择性的方案。
小干扰RNA (siRNA)已成为治疗顽固性疾病的有希望的候选药物。有效的siRNA必须具有高的靶上活性,同时将脱靶效应降至最低。这种平衡可以通过序列优化和适当的化学修饰来增强反义链的选择性来实现。无环人工核酸如丝氨酸醇核酸(SNA)在抑制脱靶作用的同时具有靶向活性。本文提供了设计sna修饰的siRNA的指南,并概述了siRNA的靶上和脱靶活性的实验评估方法,确保在细胞系统中准确的功能验证。这些方案有利于研究人员开发基于siRNA的治疗方法,以优化siRNA的选择性和有效性,同时通过创新的设计策略最大限度地减少脱靶效应。©2025 Wiley期刊有限责任公司基本方案1:sna修饰siRNA的设计基本方案2:使用反PCR设计和制备载体质粒备用方案:使用限制性内切酶和连接酶设计和制备载体质粒基本方案3:使用双荧光素酶测定法评估siRNA的靶标和脱靶效应支持方案1:琼脂糖凝胶电泳和纯化凝胶DNA的方案支持方案2:质粒的转化和扩增。
本文章由计算机程序翻译,如有差异,请以英文原文为准。